(Q30867735)

27 June 2017

1 reference

title

Loxapine for schizophrenia. (English)

1 reference

27 June 2017

0 references

M Fenton

1

1 reference

27 June 2017

B Murphy

2

1 reference

27 June 2017

J Wood

3

1 reference

27 June 2017

A Bagnall

4

1 reference

27 June 2017

P Chue

5

1 reference

27 June 2017

M Leitner

6

1 reference

27 June 2017

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

published in

1 reference

27 June 2017

issue

2

1 reference

27 June 2017

page(s)

CD001943

1 reference

Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Efficacy of loxapine in the treatment of paranoid schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Loxapine versus thioridazine in the treatment of organic psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

New dimensions in the pharmacologic treatment of schizophrenia and related psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Randomised controlled trials: sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Which atypical antipsychotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Loxapine in Newly Admitted Chronic Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Is loxapine more effective than chlorpromazine in paranoid schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

A Double-Blind Comparison of Loxapine Succinate and Trifluoperazine in Newly Admitted Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001943

10.1002/14651858.CD001943

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference